Sigma Softgel Profile
Key Indicators
- Authorised Capital ₹ 9.95 Cr
as on 08-12-2024
- Paid Up Capital ₹ 9.95 Cr
as on 08-12-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 35.86 Cr
as on 08-12-2024
About Sigma Softgel
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.95 Cr and a paid-up capital of Rs 9.95 Cr.
The company currently has active open charges totaling ₹35.86 Cr.
Ramesh Singh, Mrinal Baidyanath, Ratan Lama, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290JK2021PTC012647
- Company No.
012647
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
Company Details
- Location
Kathua, Jammu & Kashmir, India
- Telephone
- Email Address
- Website
- Social Media-
- Apps
Who are the key members and board of directors at Sigma Softgel?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Singh  | Director | 05-Mar-2024 | Current |
| Mrinal Baidyanath | Whole-Time Director | 23-Aug-2021 | Current |
| Ratan Lama | Director | 23-Aug-2021 | Current |
| Shilpa Kumari | Director | 23-Aug-2021 | Current |
Financial Performance of Sigma Softgel.
Sigma Softgel Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sigma Softgel?
Unlock access to Sigma Softgel's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rollick Healthcare Private LimitedActive 5 years 2 monthsMrinal Baidyanath and Shilpa Kumari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Aug 2024 | ₹1.00 M | Open |
Hdfc Bank Limited Creation Date: 06 Jul 2023 | ₹1.64 M | Open |
Hdfc Bank Limited Creation Date: 21 Mar 2023 | ₹35.60 Cr | Open |
How Many Employees Work at Sigma Softgel?
Sigma Softgel has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sigma Softgel, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sigma Softgel's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
